CalciMedica, Inc. — Investor Relations & Filings
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for acute inflammatory and immunologic diseases. The company specializes in the inhibition of calcium release-activated calcium (CRAC) channels, a therapeutic approach designed to modulate the immune response and protect against tissue cell injury. Its lead product candidate, Auxora™, is an intravenous formulation of the proprietary small molecule CRAC channel inhibitor, zegocractin. CalciMedica is developing Auxora for the treatment of life-threatening conditions with high unmet medical needs, including acute kidney injury (AKI) with respiratory failure and acute pancreatitis (AP), for which there are currently no approved disease-modifying treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director's Dealing 2025 | 2025-10-14 | English | |
| Director's Dealing 2025 | 2025-09-22 | English | |
| Director's Dealing 2025 | 2025-09-17 | English | |
| Director's Dealing 2025 | 2025-09-15 | English | |
| Director's Dealing 2025 | 2025-09-11 | English | |
| Major Shareholding Notification 2025 | 2025-09-09 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12507333 | Director's Dealing 2025 | 2025-10-14 | English | ||
| 12507336 | Director's Dealing 2025 | 2025-09-22 | English | ||
| 12507337 | Director's Dealing 2025 | 2025-09-17 | English | ||
| 12507338 | Director's Dealing 2025 | 2025-09-15 | English | ||
| 12507339 | Director's Dealing 2025 | 2025-09-11 | English | ||
| 12507340 | Major Shareholding Notification 2025 | 2025-09-09 | English | ||
| 12507361 | Major Shareholding Notification 2025 | 2025-09-02 | English | ||
| 12507358 | Director's Dealing 2025 | 2025-09-02 | English | ||
| 12507362 | Director's Dealing 2025 | 2025-08-25 | English | ||
| 12507363 | Director's Dealing 2025 | 2025-08-21 | English | ||
| 12507365 | Director's Dealing 2025 | 2025-08-21 | English | ||
| 12507366 | Director's Dealing 2025 | 2025-08-19 | English | ||
| 12507367 | Director's Dealing 2025 | 2025-08-18 | English | ||
| 12507373 | 10-Q | 2025-08-12 | English | ||
| 12507374 | 8-K | 2025-08-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CalciMedica, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34649/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34649 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34649 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34649 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34649}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CalciMedica, Inc. (id: 34649)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.